{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:57:48Z","timestamp":1757613468567,"version":"3.44.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91619","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:49:37Z","timestamp":1757015377000},"source":"Crossref","is-referenced-by-count":0,"title":["Seroconversion of SSA and the Development of Inflammatory Myositis in a Patient With Chronic Joint Pain: A Potential Overlap Connective Tissue Disease"],"prefix":"10.7759","author":[{"given":"Diva","family":"Maraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"El-Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Zebda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino L","year":"2013","unstructured":"Iaccarino L, Gatto M, Bettio S, et al.. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013, 12:363-73. 10.1016\/j.autrev.2012.06.004","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2011.06.009","article-title":"Lupus nephritis: role of antinucleosome autoantibodies","volume":"31","author":"van der Vlag J","year":"2011","unstructured":"van der Vlag J, Berden JH. Lupus nephritis: role of antinucleosome autoantibodies. Semin Nephrol. 2011, 31:376-89. 10.1016\/j.semnephrol.2011.06.009","journal-title":"Semin Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"Ramos-Casals M","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ. 2012, 344:e3821. 10.1136\/bmj.e3821","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.54.5.340","article-title":"Autoantibodies and overlap syndromes in autoimmune rheumatic disease","volume":"54","author":"Jury EC","year":"2001","unstructured":"Jury EC, D'Cruz D, Morrow WJ. Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol. 2001, 54:340-7. 10.1136\/jcp.54.5.340","journal-title":"J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren's syndrome: new clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals M","year":"2005","unstructured":"Ramos-Casals M, Tzioufas AG, Font J. Primary Sj\u00f6gren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005, 64:347-54. 10.1136\/ard.2004.025676","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0172-z","article-title":"Therapeutic approaches in myositis","volume":"13","author":"Aggarwal R","year":"2011","unstructured":"Aggarwal R, Oddis CV. Therapeutic approaches in myositis. Curr Rheumatol Rep. 2011, 13:182-91. 10.1007\/s11926-011-0172-z","journal-title":"Curr Rheumatol Rep"},{"key":"ref8","article-title":"Kelley's Textbook of Rheumatology. 9th ed","author":"Firestein GS","year":"2012","unstructured":"Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Kelley's Textbook of Rheumatology. 9th ed. Elsevier, Philadelphia; 2012."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1183535","article-title":"Advanced methods and novel biomarkers in autoimmune diseases \u2011 a review of the recent years progress in systemic lupus erythematosus","volume":"10","author":"Fenton KA","year":"2023","unstructured":"Fenton KA, Pedersen HL. Advanced methods and novel biomarkers in autoimmune diseases \u2011 a review of the recent years progress in systemic lupus erythematosus. Front Med (Lausanne). 2023, 10:1183535. 10.3389\/fmed.2023.1183535","journal-title":"Front Med (Lausanne)"},{"key":"ref10","article-title":"Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome","volume":"37","author":"Casal-Dominguez M","year":"2019","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, et al.. Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome. Clin Exp Rheumatol. 2019, 37:858-61.","journal-title":"Clin Exp Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.34669","article-title":"Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus","volume":"64","author":"Kalunian KC","year":"2012","unstructured":"Kalunian KC, Chatham WW, Massarotti EM, et al.. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum. 2012, 64:4040-7. 10.1002\/art.34669","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377014-seroconversion-of-ssa-and-the-development-of-inflammatory-myositis-in-a-patient-with-chronic-joint-pain-a-potential-overlap-connective-tissue-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:49:37Z","timestamp":1757015377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377014-seroconversion-of-ssa-and-the-development-of-inflammatory-myositis-in-a-patient-with-chronic-joint-pain-a-potential-overlap-connective-tissue-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.91619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}